Quantumzyme Corp.
$0.80+33.33%(+$0.20)
TickerSpark Score
40/100
60
Valuation
40
Profitability
20
Growth
48
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTZM research report →
52-Week Range16% of range
Low $0.00
Current $0.80
High $5.04
Companywww.quantumzymecorp.com
Quantumzyme Corp. operates as a biotransformation company. It develops engineered enzymes for use in active pharmaceutical ingredients production.
- CEO
- Naveen Krishnarao Kulkarni
- IPO
- 2024
- Employees
- 1
- HQ
- San Diego, CA, US
Price Chart
-31.58% · this period
Valuation
- Market Cap
- $31.17M
- P/E
- -6.36
- P/S
- 0.00
- P/B
- -67.56
- EV/EBITDA
- -310.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1014.80%
- ROIC
- 54.24%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-199,269 · 0.00%
- EPS
- $-0.01 · 0.00%
- Op Income
- $-180,537
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $5.04
- 52W Low
- $0.00
- 50D MA
- $2.67
- 200D MA
- $1.04
- Beta
- 7.51
- Avg Volume
- 79.68K
Get TickerSpark's AI analysis on QTZM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QTZM Coverage
We haven't published any research on QTZM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QTZM Report →